In The News
In The News
Q & A with Terry Day on the President’s Panel warning of the increased risk of HPV-associated oropharyngeal cancer
Human papillomavirus (HPV)-associated cancers of the oropharynx area growing problem in the United States. The incidence of these cancers is four times higher among men than women and tripled between 1988 and 2004.
Appropriate and necessary oral care for people with cancer: guidance to obtain the right oral and dental care at the right time
March 28, 2014 by Joel B. Epstein, Pelin Guneri and Andrei Barasch
The identification of experienced and knowledgeable dental specialists to provide appropriate oral care for cancer patients, as well as the integration of this care within general oncology management, may be a challenge. This paper discusses the general and additional requirements for dental care providers to support the cancer patient and provide prevention and/or treatment for oral complications of cancer therapy. Read the article here:
Study offers new look at complex head and neck tumor behavior
Head and neck squamous cell cancer (HNSCC) ranks among the top ten most prevalent cancers in the United States. Despite its prevalence, little is known about how this cancer develops and spreads. However, in a paper published in the January 29, 2015 edition of Nature, researchers offer critical new information about head and neck cancers.
Increase in Head and Neck Cancer in Younger Patients Due to Human Papillomavirus, or HPV
By David Young; Carole Fakhry, M.D., MPH; Benjamin Murphy, BS; Michael Moore, M.D.; Terry Day, M.D., FACS
The face of head and neck cancer has changed dramatically over the past 30 years. Today, patients diagnosed with throat cancer are more likely to be younger adults who have never smoked or used other tobacco products. The reason for these changes is the human papillomavirus, or HPV.
Head and neck cancer: A humanitarian effort in your own backyard
February 2, 2015 by Judith Fornadley, MS, CF-SLP; Wendy Stern, MD; Cherie-Ann O. Nathan, MD, FACS
April 12-18 is Oral, Head and Neck Cancer Awareness Week (OHANCAW).
Head and neck cancer (HNC) accounts for 5% of all new cancers, or approximately 22,000 new cases every year.1 This is a serious disease that is treatable and preventable; outcomes are best with smaller tumors (up to 90% 5-year survival with stage I disease, 75 to 80% with stage II2), which means early detection is vital. Unfortunately, several factors work against early detection.